TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Cancer Leadership Council Letter Calls For Permanent Leadership of NCI and FDA. November 22, 2006
TCL Archive Memorial Sloan Kettering Seizes Top Cancer Hospital Prize From MD Anderson In U.S. News & World Report Ranking July 18, 2014